Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX) is a Healthcare stock tracked by StreetAlpha. It last closed at $6.93 on Oct 23, down 55.52% on the day. AVTX reports earnings on Thu, Nov 5, 2026. The average 12-month price target from 4 analysts is $27.50 (+296.8% from the last close), with a high of $48.00 and a low of $10.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in AVTX, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints totaling $1.2M, the largest $471K.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 4 analysts who set a price target on AVTX in the past 90 days. The average target is $27.50, with a high of $48.00 and a low of $10.00, compared with the last close of $6.93.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 23 | Wedbush | Maintained | Buy | $22 |
| Oct 23 | BTIG | Maintained | Buy | $10 |
| Aug 7 | Guggenheim | Maintained | Buy | $48 |
| Aug 7 | HC Wainwright & Co. | Maintained | Buy | $30 |
| Jul 6 | Leerink Partners | Initiated | Buy | $38 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVTX is in one of them and how their past AVTX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AVTX in an article yet. Here's the latest on the wider market.